Effect of enzyme replacement therapy on Fabry cardiomyopathy: evaluation of cardiac function is more useful than structural evaluation
Eur Heart J Cardiovasc Imaging
.
2021 Sep 20;22(10):e148.
doi: 10.1093/ehjci/jeab078.
Authors
Hee Jun Park
1
,
Jiwon Seo
1
,
Geu Ru Hong
1
Affiliation
1
Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
PMID:
33963373
DOI:
10.1093/ehjci/jeab078
No abstract available
MeSH terms
Cardiomyopathies* / diagnostic imaging
Cardiomyopathies* / drug therapy
Enzyme Replacement Therapy
Fabry Disease* / diagnostic imaging
Fabry Disease* / drug therapy
Humans
alpha-Galactosidase
Substances
alpha-Galactosidase